Prevalence of anti-HCV and incidence rate of HCV seroconversion in a large multiregional health check-up population in China: a cross-sectional and longitudinal study of 1.6 million adults
GigaScience · 10.11.2026
DOI: 10.1093/gigascience/giag101 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift GigaScience, online erschienen am 10.11.2026. Verfasst von Sailimai Man und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
China carries one of the heaviest burdens of hepatitis C virus (HCV) infection worldwide. This study aimed to estimate the prevalence of anti-HCV and incidence rate of HCV seroconversion in a large health check-up population in China.
Methods
This cross-sectional, and longitudinal study used data from the Meinian health check-up database, covering participants from all 31 provinces of mainland China between 2017 and 2023. Serological samples were tested for anti-HCV using ELISA. The weighted prevalence of anti-HCV and the incidence rate of HCV seroconversion were calculated. Poisson regression was used to identify risk factors for HCV seroconversion.
Results
A total of 1,610,735 participants were included in the analysis of anti-HCV prevalence. The prevalence of anti-HCV in the study population was 0.89% (95% CI, 0.77%–1.01%), with significantly higher prevalence found in females and elderly individuals. Geographically, the prevalence was significantly higher in Central and West China compared to East China. Individuals with abnormal liver function or liver fibrosis, abnormal thyroid function or antibodies, diabetes, and impaired kidney function had significantly higher prevalence. The analysis of HCV seroconversion included 179,447 participants, showing an incidence rate of 0.72 per 1,000 person-years during a median follow-up of 1.5 years. Risk factors for HCV seroconversion included older age, as well as living in Central or West China, border regions, areas with low GDP per capita, and areas with high anti-HCV prevalence.
Conclusions
Our study reveals significant anti-HCV seroprevalence burden and ongoing risk of HCV transmission in a large health check-up population in China, highlighting the urgent need for systematic screening and enhanced prevention efforts to control HCV transmission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
- Peking University Health Science Center Meinian Public Health Institute, Beijing, China.
- Meinian Institute of Health, Beijing, China.
- Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Dalian Medical University, Liaoning, China.
- School of Arts and Sciences, New York University Shanghai, Shanghai, China.
ORCID-Profile: Sailimai Man, Canqing Yu, Jun Lv, Gang Li, Liming Li, Bo Wang
Zitieren
APA
Man, S., Yang, X., Zu, Y., Yu, Z., Yang, X., Deng, Y., Ma, Y., Du, J., Yu, C., Lv, J., Li, G., Li, L., & Wang, B. (2026). Prevalence of anti-HCV and incidence rate of HCV seroconversion in a large multiregional health check-up population in China: a cross-sectional and longitudinal study of 1.6 million adults. GigaScience. https://doi.org/10.1093/gigascience/giag101
Vancouver
Man S, Yang X, Zu Y, Yu Z, Yang X, Deng Y, et al. Prevalence of anti-HCV and incidence rate of HCV seroconversion in a large multiregional health check-up population in China: a cross-sectional and longitudinal study of 1.6 million adults. GigaScience. 2026. doi:10.1093/gigascience/giag101
BibTeX
@article{Man2026,
author = {Man, Sailimai and Yang, Xinmiao and Zu, Yining and Yu, Zhuoyan and Yang, Xiaochen and Deng, Yuhan and Ma, Yuan and Du, Jing and Yu, Canqing and Lv, Jun and Li, Gang and Li, Liming and Wang, Bo},
title = {Prevalence of anti-HCV and incidence rate of HCV seroconversion in a large multiregional health check-up population in China: a cross-sectional and longitudinal study of 1.6 million adults},
journal = {GigaScience},
year = {2026},
doi = {10.1093/gigascience/giag101}
}
EUVIMED